
Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…

Massive Bio is an AI-powered platform that connects cancer patients with clinical trials, enhancing access to life-saving treatments. The company leverages advanced technology and real-time data to…
What they do: AI platform that matches cancer patients to clinical trials and provides concierge enrollment support
Founded: 2014–2015 (company sources list both years)
Headquarters: New York City
Reported patients: Tens of thousands of onboarded cancer patients (reported figures: ~60,000; another source: 160,000)
Total funding (reported): Approximately $23.8M reported across disclosed rounds
Oncology clinical-trial access and patient recruitment
2014
Hospitals and Health Care
2600000
Company reported a $2.6M financing led by Revo Capital
9000000
Company reported a $9M round to scale growth and global expansion
“Includes development finance institutions, venture investors, and philanthropic backers (examples named in disclosures: DEG, IFC, Revo Capital, Charles & Lynn Schusterman Family Philanthropies)”
| Company |
|---|
About Massive Bio Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
We're recognized as a leader in health-tech innovation. Massive Bio was featured as #4 in Fast Company's Startup 100 list for Turkey and has raised $24M total funding from impact-driven investors including Revo Capital, the International Finance Corporation, and Cavendish Impact Foundation, validating both our business model and our mission-driven approach.
Role Summary You will lead a critical customer-facing operation end-to-end; from team coaching and quality assurance to process optimization and performance measurement. This leadership role focuses on building systems and culture that deliver exceptional customer experiences while maintaining operational efficiency and accountability. Your foundation will establish standards that scale as the organization grows into adjacent operational areas.
What You'll Do Team Leadership & Quality Management
Operational Excellence
Cross-Functional Collaboration
Continuous Improvement
What Will Make You Successful
Required Qualifications
Preferred
Powered by JazzHR
F5e8LRZ6aY
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week